Evangelia Tzeravini

TL;DR: The main mechanisms underlying their cardioprotective effects have been attributed to improvement in cardiac cell metabolism, improvement in ventricular loading conditions, inhibition of the Na+/H+ exchange in the myocardial cells, alteration in adipokines and cytokines production, as well as reduction of cardiac cells necrosis and cardiac fibrosis.

TL;DR: In terms of lipid-lower medication, statins improve EF in subjects with DM, whereas data from short-term trials suggest that fenofibrate improves EF; ezetimibe also improves EF but further studies are required in people with DM.

TL;DR: A comprehensive review of the available evidence regarding the role of mitochondrial adaptation and metabolic flexibility in the pathogenesis of obesity and related morbidities, namely insulin resistance states and non-alcoholic fatty liver disease (NAFLD), is presented in this article.

TL;DR: This review will present current data about the impact different interventions in the management of DFU on quality of life related parameters and the development of new, diabetic foot specific tools will help to improve knowledge in this field.

TL;DR: In a random nationwide sample of the adult population in Greece the majority of subjects with self-reported DM had type 2 DM, and most patients with type 2 were treated with OAD, while almost half of insulin naive subjects were skeptical towards insulin initiation.